# The GCO-002 CACOVID-19 Cohort: a French Nationwide Multicenter Study of COVID-19 Infected Cancer Patients

> **NCT04397575** · — · COMPLETED · sponsor: **Federation Francophone de Cancerologie Digestive** · enrollment: 1523 (actual)

## Conditions studied

- Cancer
- COVID
- Solid Tumor
- Social Inequality
- French National Cohort
- Chemotherapy
- Immunotherapy
- Surgery
- Radiotherapy

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04397575
- **Lead sponsor:** Federation Francophone de Cancerologie Digestive
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-04-03
- **Primary completion:** 2021-09-30
- **Final completion:** 2021-09-30
- **Target enrollment:** 1523 (ACTUAL)
- **Last updated:** 2022-04-04

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04397575

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04397575, "The GCO-002 CACOVID-19 Cohort: a French Nationwide Multicenter Study of COVID-19 Infected Cancer Patients". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04397575. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*